{"id":709203,"date":"2024-08-07T18:22:01","date_gmt":"2024-08-07T18:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=709203"},"modified":"2024-08-07T18:22:01","modified_gmt":"2024-08-07T18:22:01","slug":"revolutionary-ibogaine-treatment-eliminates-need-for-daily-medication-in-opiate-withdrawal","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/revolutionary-ibogaine-treatment-eliminates-need-for-daily-medication-in-opiate-withdrawal_709203.html","title":{"rendered":"Revolutionary Ibogaine Treatment Eliminates Need for Daily Medication in Opiate Withdrawal"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1723054885.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Revolutionary Ibogaine Treatment Eliminates Need for Daily Medication in Opiate Withdrawal\" src=\"https:\/\/www.abnewswire.com\/uploads\/1723054885.jpeg\" alt=\"Revolutionary Ibogaine Treatment Eliminates Need for Daily Medication in Opiate Withdrawal\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\">Ibogaien by David Dardashti,&nbsp;a leading researcher in addiction treatment,&nbsp;has announced a groundbreaking advancement in the fight against opiate withdrawal.&nbsp;Through the use of ibogaine,&nbsp;a naturally occurring psychoactive substance,&nbsp;Dardashti and his team have developed a one-time treatment that eliminates the need for daily medication in opiate withdrawal.<\/p>\n<p style=\"text-align: justify;\">&#8220;This is a game-changer in the field of addiction medicine,&#8221; said Dardashti.&nbsp;&#8220;Ibogaine has the potential to revolutionize the way we treat opiate withdrawal,&nbsp;offering a safe and effective alternative to traditional methods.&#8221;<\/p>\n<p style=\"text-align: justify;\">The traditional approach to opiate withdrawal often involves a long and difficult process of tapering off opiates,&nbsp;coupled with the use of medications like methadone or buprenorphine to manage withdrawal symptoms.&nbsp;These medications can be effective,&nbsp;but they often require daily dosing and can carry their own risks and side effects.<\/p>\n<p style=\"text-align: justify;\">In contrast,&nbsp;Dardashti&#8217;s ibogaine treatment is administered in a single session.&nbsp;The treatment works by interrupting the cycle of addiction and resetting the brain&#8217;s neurochemistry.&nbsp;In many cases,&nbsp;patients report a significant reduction in withdrawal symptoms within hours of treatment.<\/p>\n<p style=\"text-align: justify;\">&#8220;Our ibogaine treatment has shown remarkable results in clinical trials,&#8221; said Dardashti.&nbsp;&#8220;Patients who have struggled with opiate addiction for years have been able to overcome their withdrawal symptoms and achieve lasting recovery.&#8221;<\/p>\n<p style=\"text-align: justify;\">Dardashti&#8217;s ibogaine treatment is not without its critics.&nbsp;Some researchers have raised concerns about the safety of ibogaine,&nbsp;citing potential side effects like cardiovascular complications.&nbsp;However,&nbsp;Dardashti maintains that his treatment protocol is safe and effective when administered by trained professionals.<\/p>\n<p style=\"text-align: justify;\">&#8220;We have a rigorous screening process to ensure that patients are suitable candidates for ibogaine treatment,&#8221; said Dardashti.&nbsp;&#8220;We also closely monitor patients during and after treatment to manage any potential side effects.&#8221;<\/p>\n<p style=\"text-align: justify;\">Dardashti&#8217;s ibogaine treatment has the potential to transform the lives of millions of people struggling with opiate addiction.&nbsp;By eliminating the need for daily medication,&nbsp;this revolutionary treatment offers a new path to recovery that is both safe and effective.<\/p>\n<p style=\"text-align: justify;\"><strong>About David Dardashti<\/strong><\/p>\n<p style=\"text-align: justify;\">David Dardashti is a leading researcher and clinician in the field of addiction medicine.&nbsp;He has dedicated his career to developing innovative treatments for addiction,&nbsp;with a particular focus on the use of ibogaine.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/ibogaineclinic.com_137017.html\" rel=\"nofollow\">Ibogaine By David Dardashti<\/a><br \/><strong>Contact Person:<\/strong> Cole Barressi <br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=revolutionary-ibogaine-treatment-eliminates-need-for-daily-medication-in-opiate-withdrawal\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.ibogaineclinic.com\" target=\"_blank\" rel=\"nofollow\">www.ibogaineclinic.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.ibogaineclinic.com\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=revolutionary-ibogaine-treatment-eliminates-need-for-daily-medication-in-opiate-withdrawal\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ibogaien by David Dardashti,&nbsp;a leading researcher in addiction treatment,&nbsp;has announced a groundbreaking advancement in the fight against opiate withdrawal.&nbsp;Through the use of ibogaine,&nbsp;a naturally occurring psychoactive substance,&nbsp;Dardashti and his team have developed a one-time treatment that eliminates the need for &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/revolutionary-ibogaine-treatment-eliminates-need-for-daily-medication-in-opiate-withdrawal_709203.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[400,418,447,424,402],"tags":[],"class_list":["post-709203","post","type-post","status-publish","format-standard","hentry","category-Agriculture-Farming","category-Building-Construction","category-Education","category-Family-Parenting","category-Food-Beverage"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/709203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=709203"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/709203\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=709203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=709203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=709203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}